Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 12
Submit an article Journal homepage
545
Views
19
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study

Emilio IannittoA.O.U. Policlinico Paolo Giaccone, Palermo, ItalyCorrespondence[email protected]
,
Stefano LuminariUniversity of Modena and Reggio Emilia, Modena, Italy
,
Claudio TripodoUniversity of Palermo, Palermo, Italy
,
Salvatrice MancusoA.O.U. Policlinico Paolo Giaccone, Palermo, Italy
,
Marina CesarettiUniversity of Modena and Reggio Emilia, Modena, Italy
,
Luigi MarcheselliUniversity of Modena and Reggio Emilia, Modena, Italy
,
Francesco MerliArcispedale S. Maria Nuova – IRCCS, Reggio Emilia, Italy
,
Caterina StelitanoAzienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy
,
Angelo Michele CarellaAzienda Ospedaliera Universitaria “San Martino”, Genova, Italy
,
Alberto FragassoPresidio Ospedaliero Madonna delle Grazie, Matera, Italy
,
Elisa MontechiarelloAzienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy
,
Giuseppina RicciutiDepartment of Hematology, Pescara, Italy
,
Alessandro PulsoniUniversity La Sapienza, Roma, Italy
,
Marco PaulliUniversity of Pavia and Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Policlinico, San Matteo, Pavia, Italy
,
Vito FrancoUniversity of Palermo, Palermo, Italy
&
Massimo FedericoUniversity of Modena and Reggio Emilia, Modena, Italy
 show all
Pages 3281-3287 | Received 11 Aug 2014, Accepted 05 Mar 2015, Published online: 18 Jul 2015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.